Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
- 1 August 1997
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 350 (9078), 607-614
- https://doi.org/10.1016/s0140-6736(97)03022-5
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- The relation between treatment benefit and underlying risk in meta-analysisBMJ, 1996
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeThe New England Journal of Medicine, 1996
- European Strategies for Early Intervention in Stroke (Part 1 of 2)Cerebrovascular Diseases, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- Patient preferences for stroke outcomes.Stroke, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- Controversies in meta-analysis: the case of the trials of serum cholesterol reductionStatistical Methods in Medical Research, 1993
- Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.Stroke, 1993
- Thrombolysis in acute ischemic stroke: does it work?Stroke, 1992